Mixture of MMP-2, MLC, and NOS Inhibitors Affects NO Metabolism and Protects Heart from Cardiac I/R Injury.
Anna Krzywonos-ZawadzkaAleksandra FranczakGrzegorz SawickiIwona Bil-LulaPublished in: Cardiology research and practice (2020)
Synergistic effect of the multidrug therapy with the subthreshold doses allows addressing a few pathways of I/R injury simultaneously to achieve protection of cardiac function during I/R.